Home/Purple Biotech/Isaac Israel

II

Isaac Israel

Chief Executive Officer

Therapeutic Areas

Purple Biotech Pipeline

Drug	Indication	Phase
CM24	Non-Small Cell Lung Cancer	Phase 2
NT219	Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma	Phase 1/2

Leadership Team at Purple Biotech

Chief Financial Officer

Mikael D. Törnqvist

Chief Scientific Officer

View full Purple Biotech profile